Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Daxor Corporation, a Nasdaq-listed medical diagnostics company specializing in precise blood volume measurement technology, delivered a mid-year corporate update highlighting its financial strength, commercial expansion with new sales leadership, manufacturing capacity investments, and ongoing clinical validation supporting its innovative next-gene…
ProMIS Neurosciences Inc., a clinical-stage biotech developing antibody therapeutics for neurodegenerative diseases, announced participation in several key investor and healthcare conferences throughout September 2026. The company will present updates on its EpiSelect™ platform and lead candidate PMN310, currently in an ongoing Phase 1b trial for e…
22nd Century Group, a Nasdaq-listed leader in low-nicotine tobacco products, reports accelerating growth with expanded retail presence from 2,000 to an expected 5,000 outlets by year-end 2026, improved gross margins driven by branded products, and consistent monthly sales growth. The company remains focused on commercial execution and innovation, l…
Wetour Robotics Limited has demonstrated its Orchestra system, integrating surface electromyography (sEMG) wristband data with first-person vision to overcome limitations of vision-only robot training. The fusion of muscle activation data with visual input enables more accurate capture of hand movement and force, even during occlusions, improving d…
BIO-key International, a leader in biometric identity and access management solutions, announced that CEO Michael DePasquale will participate in virtual meetings and present at the H.C. Wainwright Global Investment Conference in September 2026. The company's presentation will be available on demand to registered attendees, highlighting its biometri…
Emergent BioSolutions has been awarded a $24 million contract modification by BARDA, part of the U.S. Department of Health and Human Services, to supply its CYFENDUS® anthrax vaccine. This contract supports the U.S. government's ongoing anthrax preparedness efforts amid biological threats. CYFENDUS®, FDA-approved in 2023 for post-exposure prophylax…
Domino's shares have pulled back into the low $300s after a rough summer for restaurant stocks. The business still generates strong free cash flow ($653m last reported year), pays a 2.16% dividend and trades below historical multiples. Management's self-help initiatives (menu/marketing, digital execution and international expansion) plus a valuatio…
3 E Network Technology Group Limited announced that its wholly owned subsidiary secured a $1.2 million sales order for enterprise-grade DDR4 memory chips. This order demonstrates the company's capabilities in hardware supply amid growing IT infrastructure upgrades and provides additional revenue to support its AI infrastructure R&D efforts. The ord…
Sezzle Inc. announced that Gymshark, Debenhams Group (including its multiple brands), and Follett Higher Education are now offering Sezzle as a payment option at checkout. This expansion comes during a record back-to-school shopping season, providing flexible payment solutions for budget-conscious students and families. With Sezzle's point-of-sale …
Kayne Anderson Energy Infrastructure Fund, Inc. declared a monthly distribution of $0.09 per common share payable on September 30, 2026. The fund focuses on energy infrastructure securities and aims to provide high after-tax returns with an emphasis on cash distributions. Distribution amounts may vary and are subject to Board approval and financial…
Heidmar Maritime Holdings Corp. reported robust second quarter and first half 2026 results with total revenues of $29.0 million in Q2, a significant increase from $9.6 million in Q2 2025, driven by growth in commercially managed vessels and higher chartering activity. Net income attributable to shareholders rose to $2.2 million in Q2 2026 compared …
Kala Bio and Virotek announced a letter of intent to establish an exclusive U.S. distribution partnership where Kala will market and distribute Virotek's genetic testing program for ophthalmology. This collaboration aligns with Kala's strategic focus on eye care and provides a near-term commercial revenue opportunity while extending Kala's reach in…
NorthStrive Biosciences, a subsidiary of PMGC Holdings (NASDAQ: ELAB), announced an expanded three-phase program with Yuva Biosciences to advance four AI-discovered compounds toward lead nomination for developing potential therapies in cardiac diseases and obesity. The program builds upon positive Phase III results and aims to de-risk and narrow ca…
Clearmind Medicine Inc. has initiated Phase IIa of its Phase I/IIa clinical trial evaluating CMND-100, a non-hallucinogenic psychedelic-derived therapeutic candidate, for the treatment of Alcohol Use Disorder (AUD). Six patients have been enrolled so far across medical centers in Israel, marking progression into the multiple-dose treatment phase fo…
Gran Tierra Energy's plan to sell its Colombia and Ecuador businesses, combined with improving Q2 results and cheap valuation metrics (EV/EBITDA ~2.8, P/S 0.56), creates a clear asymmetric trade. If proceeds are used to pay down debt and simplify the asset base, the market could re-rate the stock. This trade targets reopening the re-rating over the…
Stoke Therapeutics and Biogen presented 4-year clinical data showing sustained improvements in cognition, behavior, and durable seizure reductions with a generally well-tolerated safety profile for zorevunersen, an investigational antisense oligonucleotide targeting the underlying cause of Dravet syndrome. The ongoing global Phase 3 EMPEROR study a…
Comstock Resources announced a strategic partnership with SOCAR involving the sale of non-operated interests in its Legacy and Western Haynesville assets and Pinnacle Gas Services for $1.65 billion in cash. Additionally, Comstock entered a $450 million drilling joint venture with majority stockholder Jerry Jones to fund drilling of Haynesville well…
USBC, a publicly traded technology company focused on tokenized deposits, announced the hiring of Richa Pareek as Chief Product Officer. Pareek brings extensive experience from JPMorgan Chase, Coinbase, and other leading tech firms. Her appointment coincides with the next phase of USBC's product testing and platform development for their blockchain…
Telesat Government Solutions, a US-based subsidiary of Telesat Corporation (TSAT), has signed a strategic collaboration with Cailabs US, Inc. to integrate secure, resilient, high-capacity optical space-to-ground connectivity for U.S. Government and allied missions. The partnership aims to combine Telesat's Lightspeed LEO satellite network with Cail…
FocalTherics, a leader in robotic focal therapy, announced that its CEO and CFO will present and host investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 15-16, 2026. The company focuses on minimally invasive medical devices leveraging proprietary focused ultrasound technology to treat various …
Streamex Corp., a Nasdaq-listed technology company specializing in tokenization of commodity assets, appointed Laura Kiernan as Head of Investor Relations. Kiernan brings over 30 years of capital markets experience to lead investor relations strategy, aiming to bridge the value of Streamex's platform with market perception. The move supports Stream…
Ardelyx Inc., a US commercial-stage biopharmaceutical company, has announced its participation in several major investor conferences in New York during September 2026, including Citi, Cantor, and Morgan Stanley healthcare events. The company will host fireside chats and investor meetings, providing updates on its commercial products IBSRELA and XPH…
BridgeBio Pharma, a biopharmaceutical company focused on genetic condition medicines, announced that its management will participate in several upcoming healthcare investor conferences in September 2026. These include Wells Fargo, Cantor Global, Morgan Stanley, and Bernstein Insights conferences. The company aims to communicate its developments and…
KANZHUN LIMITED, a leading Chinese online recruitment platform, announced the rotation of its president position effective September 1, 2026. Mr. Xu Chen steps down as president but remains as executive director and Chief Marketing Officer, while Mr. Tao Zhang takes over as rotating president alongside his roles as executive director and Chief Tech…
Alumis announced that its Phase 2b LUMUS trial of envudeucitinib in moderate-to-severe systemic lupus erythematosus (SLE) did not meet primary and secondary endpoints in the overall population. However, robust responses in the prespecified interferon gene signature-high (IFNGS-high) subgroup, representing most moderate-to-severe SLE cases, support …
